UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058785
Receipt number R000067149
Scientific Title Investigating Behavioral Changes Among Older Adults in Response to Personalized Interventions Aimed at Enhancing Cognitive Reserve
Date of disclosure of the study information 2025/08/13
Last modified on 2025/08/13 14:54:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of tailor-made behavior modification program based on cognitive function simulation, main study

Acronym

PREPARE study, main study

Scientific Title

Investigating Behavioral Changes Among Older Adults in Response to Personalized Interventions Aimed at Enhancing Cognitive Reserve

Scientific Title:Acronym

Investigating Behavioral Changes Among Older Adults in Response to Personalized Interventions Aimed at Enhancing Cognitive Reserve

Region

Japan


Condition

Condition

Healthy adults over the age of 65

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This exploratory study aims to investigate the extent to which the use of a cognitive reserve simulation app, in addition to educational interventions for dementia prevention, promotes behavior change toward dementia-preventive actions among healthy older adults with a low risk of dementia. The study will also examine the use of cognitive training tools and the duration of sustained behavioral changes.

Basic objectives2

Others

Basic objectives -Others

This exploratory study aims to examine the extent to which the use of a cognitive reserve simulation app, in addition to educational interventions for enhancing cognitive reserve, can promote behavior change aimed at improving cognitive reserve among healthy older adults with a low risk of dementia. Furthermore, the study will investigate the sustainability of these behavioral changes by assessing the use of cognitive training tools and conducting a follow-up survey on daily lifestyle behaviors over a six-month period.

This study is an expanded follow-up to a pilot study conducted in 2024, designed to address the aforementioned clinical questions.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

-the evaluation calculated by Cognitive Researve Simulation App.
-the test score of Cognitive Function Training Tool

Key secondary outcomes

-the score of Health Belief Model for Dementia Prevention
-the score of MMSE
-the score of CQtest
-the score of adherence test


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

The cognitive reserve simulation app will be used once at baseline.

Interventions/Control_2

The cognitive reserve simulation app will not be used at baseline.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Individuals aged 65 years or older
2. Individuals who have never been diagnosed with dementia
3. Individuals who have provided written informed consent to participate in this study
4. Individuals who are able to use a smartphone or tablet with access to the internet

Key exclusion criteria

Participants who meet any of the following criteria will be excluded from this study
1. Individuals who have difficulty responding to assessment scales or operating a tablet device
2. Individuals with an MMSE score of 23 or lower
3. Individuals deemed unsuitable for participation in this study by the principal investigator or co-investigators

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Mimura

Organization

Keio University

Division name

Center for Preventive Medicine

Zip code

106-0041

Address

7th Floor, Azabudai Hills Mori JP Tower, 1-3-1 Azabudai, Minato-ku, Tokyo, Japan

TEL

03-3353-1211

Email

mimura.a7@keio.jp


Public contact

Name of contact person

1st name Taishiro
Middle name
Last name Kishimoto

Organization

Keio University School of Medicine

Division name

Center for the Promotion of Interdisciplinary Research in Medicine and Life Science (PIRMS)

Zip code

106-0041

Address

7th Floor, Azabudai Hills Mori JP Tower, 1-3-1 Azabudai, Minato-ku, Tokyo

TEL

03-5363-3219

Homepage URL


Email

tkishimoto@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Splink Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Keio University, School of Medicine

Address

35 Shinanomachi Shinjuku Tokyo

Tel

0353633503

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

港区シルバー人材センター(東京都)


Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 04 Month 30 Day

Date of IRB


Anticipated trial start date

2025 Year 08 Month 19 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 13 Day

Last modified on

2025 Year 08 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067149